Vertex To Present at Morgan Stanley Healthcare Conference
Morgan Stanley Global Healthcare Conference 2013
CAMBRIDGE, Mass. -- September 5, 2013
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it
will webcast its presentation at the Morgan Stanley Global Healthcare
Conference on Tuesday, September 10, 2013 at 8:00 a.m. ET.
The presentation will be webcast live and may be accessed from the ‘Events &
Presentations' link under the ‘Investors' tab on the home page of Vertex's
website at www.vrtx.com. A replay of the webcast will also be available on the
Company's website for two weeks following the presentations. To ensure a
timely connection, it is recommended that users register at least 15 minutes
prior to the scheduled webcast.
Vertex creates new possibilities in medicine. Our team discovers, develops and
commercializes innovative therapies so people with serious diseases can lead
Vertex scientists and our collaborators are working on new medicines to cure
or significantly advance the treatment of hepatitis C, cystic fibrosis,
rheumatoid arthritis and other life-threatening diseases.
Founded more than 20 years ago in Cambridge, Mass., we now have ongoing
worldwide research programs and sites in the U.S., U.K. and Canada. Today,
Vertex has more than 2,000 employees around the world, and for three years in
a row, Science magazine has named Vertex one of its Top Employers in the life
Vertex's press releases are available at www.vrtx.com.
Vertex Pharmaceuticals Incorporated
Kelly Lewis, 617-961-7530
Director, Investor Relations
Press spacebar to pause and continue. Press esc to stop.